ARTICLE | Clinical News
Vanoxerine: Phase III started
September 21, 2015 7:00 AM UTC
Laguna began the double-blind, placebo-controlled, international Phase III RESTORE SR trial to evaluate a single dose of 400 mg oral vanoxerine in about 600 patients. ...